Growth Metrics

Collegium Pharmaceutical (COLL) Other Non-Current Assets (2016 - 2025)

Collegium Pharmaceutical has reported Other Non-Current Assets over the past 10 years, most recently at $20.2 million for Q4 2025.

  • Quarterly results put Other Non-Current Assets at $20.2 million for Q4 2025, up 1828.65% from a year ago — trailing twelve months through Dec 2025 was $20.2 million (up 1828.65% YoY), and the annual figure for FY2025 was $20.2 million, up 1828.65%.
  • Other Non-Current Assets for Q4 2025 was $20.2 million at Collegium Pharmaceutical, up from $1.1 million in the prior quarter.
  • Over the last five years, Other Non-Current Assets for COLL hit a ceiling of $20.2 million in Q4 2025 and a floor of $100000.0 in Q4 2022.
  • Median Other Non-Current Assets over the past 5 years was $1.8 million (2021), compared with a mean of $2.7 million.
  • Biggest five-year swings in Other Non-Current Assets: crashed 96.07% in 2022 and later soared 1828.65% in 2025.
  • Collegium Pharmaceutical's Other Non-Current Assets stood at $2.5 million in 2021, then crashed by 96.07% to $100000.0 in 2022, then skyrocketed by 947.0% to $1.0 million in 2023, then changed by 0.0% to $1.0 million in 2024, then soared by 1828.65% to $20.2 million in 2025.
  • The last three reported values for Other Non-Current Assets were $20.2 million (Q4 2025), $1.1 million (Q3 2025), and $1.0 million (Q2 2025) per Business Quant data.